Impacts of interleukin-12 on multiplication of Mycobacterium tuberculosis and Mycobacterium avium complex in mice
Open Access
- 1 June 1999
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 5 (6) , 331-338
- https://doi.org/10.1111/j.1469-0691.1999.tb00152.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Protection of mice from Mycobacterium avium infection by recombinant interleukin-12Antimicrobial Agents and Chemotherapy, 1995
- Administration of Recombinant Interleukin-12 to Mice Suppresses Hematopoiesis in the Bone Marrow but Enhances Hematopoiesis in the SpleenJournal of Interferon & Cytokine Research, 1995
- Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse modelAntimicrobial Agents and Chemotherapy, 1994
- Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Enhances the Effects of Antibiotics against Mycobacterium avium Complex Infection in the Beige Mouse ModelThe Journal of Infectious Diseases, 1994
- Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDSNew England Journal of Medicine, 1993
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive PatientsThe Journal of Infectious Diseases, 1992
- In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosisTubercle, 1991
- Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experimentsTubercle, 1991
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989